Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis

CONCLUSIONS: Proper patient selection for tertiary cytoreduction is essential. Those who achieve CGR likely derive the greatest benefit from tertiary surgery. Platinum sensitivity and prolonged TFI are also associated with improved DSS. Patients with HGSOC and single-site recurrence who were ≥2 years out from secondary cytoreduction had the longest DSS.PMID:34045053 | DOI:10.1016/j.ygyno.2021.05.015

Source: Gynecologic Oncology - May 28, 2021 Category: Cancer & Oncology Authors: Beryl L Manning-Geist Dennis S Chi Kara Long Roche Oliver Zivanovic Yukio Sonoda Ginger J Gardner Roisin E O'Cearbhaill Nadeem R Abu-Rustum Mario M Leitao Source Type: research